OLINK® | Comprehensive Biomarker Discovery
Let Experts at Randox Run Your Samples
As one of the UK’s first commercial partners of Olink® Proximity Extension Assay (PEA) technology, Randox offer scientists involved in drug development, clinical, or basic life science research, the service they need to run large-scale discovery proteomics.
Considered as a next-gen proteomics platform, Olink® technology is widely recognised and extensively cited in various research fields for protein profiling and biomarker development.
As an Olink® Certified Service Provider, Randox are experts in generating high-quality data using all Olink® proteomic platforms.
Supported Olink® Platforms
Randox Service portfolio includes high throughput protein analysis using cutting-edge Olink® technology. We are experts in generating high-quality data using all Olink® proteomic platforms. Allow the Randox team to assist you in discovering how this versatile assay can advance your research by getting in touch or visiting the Olink® Website.
Olink® Explore HT
Proteins (per panel): 5,400 +
Sample: 2 µL
Multiplex Panels: 1
Quantification: Relative
Olink® Explore 384
Proteins (per panel) ~3000
Sample: 1 µL
Multiplex Panels: 8
Quantification: Relative
Olink® Target 96
Proteins (per panel) ~ 1100
Sample: 1 µL
Multiplex Panels: 15
Quantification: Relative
Olink® Target 48 Cytokine
Proteins (per panel): 45
Sample: 1 µL
Multiplex Panels: 1
Quantification: Relative
Olink® Flex
Proteins (per panel) ~200
Sample: 1 µL
Multiplex Panels: Mix & Match
Quantification: Relative or absolute
Olink® Focus
Proteins (per panel) 5400+
Sample: 1 µL
Multiplex Panels: Custom
Quantification: Relative or absolute
Randox Successfully Completed Olink® Concordance Testing
Randox successfully completed the Explore Concordance challenge as beta testers of the Concordance program, certifying the ability to operate the PEA with the same level of competency as the Olink® Analysis Service.
Randox Summary Report | Acceptance Criteria | Result | |
---|---|---|---|
QC Warnings | 0% | Max 16% allowed | Passed the QC warning criteria |
Detectability | 97.2% | Min 85% allowed | Passed the detectability criteria |
Intra CV | 9% | Max 15% allowed | Passed the CV criteria |
Median correlation coefficient (r) | 0.98 | Min 0.9 allowed | Passed the correlation criteria. |
Coefficient of determination (R2) | 0.96 | Min 0.9 allowed | Passed the correlation criteria. |